But using cells drawn from umbilical cord blood, Rezvani’s team have been able to manufacture around 40 million CD19-targeting chimeric natural killer cells in two weeks. She told the conference ...

For a source of NK cells, Rezvani turned to umbilical-cord blood. This source provides a large number of NK cells from healthy individuals, which work better than those from patients with cancer.

Among other functions, the NK cells (natural killers, a type of lymphocyte forming part of the immune system) have the capacity to detect and eliminate cancer cells. But in some cases they cannot ...